Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1515/cclm-2021-0324
Twittear
Título: | Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection |
Fecha de publicación: | 28-abr-2021 |
Cita bibliográfica: | Clinical Chemistry and Laboratory Medicine (CCLM) 59( 9) (2021): 1592–1599 |
ISSN: | Print: 1434-6621 Electronic: 1437-4331 |
Palabras clave: | Analytical validation Assay Biomarkers COVID-19 SARS-CoV-2 |
Resumen: | Objectives: The aim of the present study was to validate a commercially available automated assay for the measurement of total adenosine deaminase (tADA) and its isoenzymes (ADA1 and ADA2) in saliva in a fast and accurate way, and evaluate the possible changes of these analytes in individuals with SARS-CoV-2 infection. Methods: The validation, in addition to the evaluation of precision and accuracy, included the analysis of the effects of the main procedures that are currently being used for SARS-CoV-2 inactivation in saliva and a pilot study to evaluate the possible changes in salivary tADA and isoenzymes in individuals infected with SARS-CoV-2. Results: The automated assay proved to be accurate and precise, with intra- and inter-assay coefficients of variation below 8.2%, linearity under dilution linear regression with R2 close to 1, and recovery percentage between 80 and 120% in all cases. This assay was affected when the sample is treated with heat or SDS for virus inactivation but tolerated Triton X-100 and NP-40. Individuals with SARS-CoV-2 infection (n=71) and who recovered from infection (n=11) had higher mean values of activity of tADA and its isoenzymes than healthy individuals (n=35). Conclusions: tADA and its isoenzymes ADA1 and ADA2 can be measured accurately and precisely in saliva samples in a rapid, economical, and reproducible way and can be analyzed after chemical inactivation with Triton X-100 and NP-40. Besides, the changes observed in tADA and isoenzymes in individuals with COVID-19 open the possibility of their potential use as non-invasive biomarkers in this disease. |
Autor/es principal/es: | Franco Martínez, Lorena Tecles, Fernando Torres Cantero, Alberto Bernal, Enrique San Lázaro, Indra Alcaraz, María José Vicente Romero, Rosario Lamy, Elsa Sánchez Resalt, Cristina Rubio, Camila P. Tvarijonaviciute, Asta Martínez Subiela, Silvia Cerón, José J. |
Facultad/Departamentos/Servicios: | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU:: Medicina y Cirugía Animal |
Versión del editor: | https://www.degruyter.com/document/doi/10.1515/cclm-2021-0324/html |
URI: | http://hdl.handle.net/10201/139072 |
DOI: | https://doi.org/10.1515/cclm-2021-0324 |
Tipo de documento: | info:eu-repo/semantics/article |
Número páginas / Extensión: | 8 |
Derechos: | info:eu-repo/semantics/embargoedAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
Descripción: | ©2021. This document is the published, version of a Published Work that appeared in final form in Clinical Chemistry and Laboratory Medicine (CCLM). To access the final edited and published work see https://doi.org/10.1515/cclm-2021-0324 |
Aparece en las colecciones: | Artículos: Medicina y Cirugía Animal |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
10.1515_cclm-2021-0324-1.pdf | 387,1 kB | Adobe PDF | Visualizar/Abrir Solicitar una copia |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.